By Ludwig Burger (Reuters) -Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff ...

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it ...

Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Roche Holding, the Swiss pharmaceutical giant, said on Thursday that its group sales rose by 7% in the first quarter to 14.4 ...

Several major drugmakers are counting on their manufacturing flexibility to counter potential disruptions from tariffs ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats of imposing tariffs on the industry, Roche’s CEO has warned. | Big Pharma ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.